Pfizer Inc. — Sponsor Intelligence | 155 EU Trials

Filter these 155 trials by condition, phase, country and more.

Open in Search →

155 Registered trials

47 Recruiting

96 Completed trials

22 Countries active

146 Unique IMPs

100% Results reported

Phase III

Phase II

Phase I (Other)

Phase III: 52 Phase II/III: 4 Phase II: 24 Phase I/II: 12 Phase IV: 7 Phase I: 12 Phase I (Other): 38 Phase I (FiH): 1 Other: 5

Oversight events:

1 serious breach 43 temporary halts 1 urgent safety measure 1 unexpected event 4 corrective measures across 17 trials

View oversight register →

100%

96 of 96 completed trials have published summary results (EU CTR Article 37 — 12-month obligation).

View full Transparency Scoreboard →

Top indications

Non-small cell lung cancer 8 Alopecia areata 8 Migraine 6 Prostate cancer metastatic 6 Respiratory syncytial virus infection 4 Non-small cell lung cancer metastatic 4 HER2 positive breast cancer 3 Small cell lung cancer 3 Colorectal cancer 3 Malignant melanoma 3 Obesity 3 Colitis ulcerative 3

Top IMPs

RITLECITINIB TOSILATE 10 PF-08634404 7 (3S)-3-[6-[4-[[1-[4-[(1R,2S)-6-HYDROXY-2-PHENYL-1,2,3,4-TETRAHYDRONAPHTHALEN-1-YL]PHENYL]PIPERIDIN-4-YL]METHYL]PIPERAZIN-1-YL]-3-OXO-1H-ISOINDOL-2-YL]PIPERIDINE-2,6-DIONE 6 ELRANATAMAB 6 PF-07220060 MONOHYDRATE 6 RIMEGEPANT 6 DEXAMETHASONE 4 ENZALUTAMIDE 4 HUMAN NORMAL IMMUNOGLOBULIN 4 PALBOCICLIB 4 5,8-DICHLORO-2-[(4-METHOXY-6-METHYL-2-OXO-1,2-DIHYDROPYRIDIN-3-YL)METHYL]-7-[(R)-METHOXY(OXETAN-3-YL)METHYL]-3,4-DIHYDROISOQUINOLIN-1(2H)-ONE 3 ABROCITINIB 3

All trials — page 5

155 total

A Phase 1 study to evaluate the metabolism of [14C]PF-07104091 in healthy adult male participants Ended

2024-518696-65-00 Phase I (Other) 1 country
A Study to Learn How Different Amounts of the Study Medicine Called PF-07940369 are Tolerated and Act in the Body in Healthy Adults Ended

2025-520558-12-00 Phase I (Other) 1 country
A Study of PF-08046031 in Adults With Advanced Melanoma and Other Solid Tumors Ended

2024-514745-10-00 Phase I 5 countries
A study to learn how the study medicine called [14C]PF-07054894 is processed by the body. Ended

2024-519882-23-00 Phase I (Other) 1 country
A Study to Understand What the Body Does to the Study Medicine Called PF-07976016 When Taken by Healthy Adults Ended

2024-518535-11-00 Phase I (Other) 1 country
A study to learn about the study medicine called PF-08046032 in people with advanced cancers. Ended

2024-517756-35-00 Phase I (Other) 1 country
A Study to Learn About the Study Medicine Called PF-07976016 in Adults With Obesity Ended

2024-513679-42-00 Phase II 2 countries LIRAGLUTIDE; PF-07976016-87
A Study to Learn How a Tablet Compared with an IV Infusion of the Study Medicine Called Vepdegestrant is Taken up into the Blood in Healthy … Ended

2024-518134-92-00 Phase I (Other) 1 country
A study to Learn If Study Medicines Called Cyclosporine and Clarithromycin Affect How the Body Processes the Other Study Medicine Called PF-… Ended

2024-520126-11-00 Phase I (Other) 1 country
A study to establish the bioequivalence of free acid tafamidis 61 mg capsule and tablet, and evaluate the safety and tolerability of the 61 … Ended

2024-514166-40-00 1 country
A study to learn how different amounts of the study medicine called PF-07941944 are tolerated in the body of healthy adults. Ended

2024-515421-28-00 Phase I 1 country
A Study to Learn About How Different Formulations of the Medicine Called Mevrometostat are Taken up Into the Blood in Healthy Adult Particip… Ended

2024-516907-18-00 Phase I (Other) 1 country
A Study to Learn About if the Study Medicine Called Ibuzatrelvir changes how the body process the other Medicine Dabigatran Etexilate in hea… Ended

2024-517797-14-00 Phase I (Other) 1 country
A Study to Learn About the Study Medicine Called PF-07220060 in Combination With Letrozole Compared to Letrozole Alone in Postmenopausal Wom… Ended

2024-512848-30-00 Phase II 8 countries LETROZOLE; PF-07220060 MONOHYDRATE
A Study to Learn how Various Tablets of the Study Medicine Called Vepdegestrant are Taken up into the Blood in Healthy Adults Ended

2024-514169-21-00 Phase I (Other) 1 country
A Study to Learn How Different Amounts and Forms of the Study Intervention Called PF-07899895 are Tolerated and Act in the Body of Healthy A… Ended

2023-507354-32-00 Phase I 1 country
A Study to Learn How Different Amounts of the Study Medicine Called PF-07940369 are Tolerated and Act in the Body in Healthy Adults. Ended

2024-513467-47-00 Phase I 1 country
A Study in Healthy Adult Male Participants to Evaluate the Metabolism of [14C]PF-06821497 Ended

2023-508371-36-00 Phase I (Other) 1 country
A Study to Learn How Different Forms of Study Medicine CTB-AVP Are Taken up Into the Blood and How It Is Taken up Into The Blood When Taken … Ended

2023-507117-10-00 Phase I (Other) 1 country
A Study to Learn About the Study Medicine Called PF-07054894 in People of Japanese Origin Ended

2023-509339-17-00 Phase I (Other) 1 country
TACTIVE-U: An Umbrella Study to Investigate the Safety and Antitumor Activity of vepdegestrant (ARV-471) in Combination With Other Medicines… Ended

2023-507125-41-00 Phase I/II 4 countries (3S)-3-[6-[4-[[1-[4-[(1R,2S)-6-HYDROXY-2-PHENYL-1,2,3,4-TETRAHYDRONAPHTHALEN-1-Y…
A Study to Learn How Different Amounts of the Study Medicine Called PF-07328948 are Tolerated and Act in the Body in Healthy Adults Ended

2023-509054-54-00 Phase I (Other) 1 country
A study to learn how different forms of study medicine tafamidis are taken up into the blood in healthy adults Ended

2023-509241-12-00 Phase I (Other) 1 country TAFAMIDIS
A Study to Learn If the Study Medicine Called Vepdegestrant Changes How the Body Processes the Other Study Medicine Called Midazolam Ended

2023-508518-40-00 Phase I (Other) 1 country

Showing 97–120 of 155 trials

← All sponsors A–Z